World-class research matched by world-class facilities
Medicon Valley is home to pioneering research that is breaking new ground in cancer treatment, diabetes, inflammation and neurological disorders. World-class research is matched by world-class facilities with knowledge sharing networks, advanced medical record databases, comprehensive health registers, and support organisations ready to help you excel. If you are looking to develop new technologies and a strong foundation for clinical trials Medicon Valley provides the innovative environment you are looking for.
Medicon Valley has more than 10 companies dedicated solely to diabetes research, making this area a world leader in diabetes care. There are currently over 40 compounds in the pipeline for diabetes and metabolic disease, with a large portion of the cluster’s R&D expenditure focused on this field.
LUDC (Lund University Diabetes Centre) and AFC (the Anti-diabetic Food Centre) at Lund University and Center for Diabetes Research at Gentofte Hospital and the Novo Nordisk Foundation Center for Basic Metabolic Research in Denmark make Medicon Valley the home of one of the largest and most respected diabetes research centers in the world.
Applied Neuroscience is another area in which Medicon Valley excels, and is considered to be a world leader. Although the volume of organisations in the region is small, there are over 60 compounds in development.
The multidisciplinary research at the Wallenberg Research Centre focuses on understanding neurodegenerative diseases. The centre studies cell and animal models of Huntington and Parkinson diseases to develop therapies that benefit both patients and their caregivers.
Additionally an Epilepsy Center was recently established in Lund as part of a large European project. Advancements are being achieved through the strong cooperation with other universities and industry leaders within Medicon Valley.
Research at The Brain Research and Integrative Neuroscience Laboratory (BRAINlab) at Copenhagen University is aimed at understanding normal, pathological and adaptive brain functioning, both at the molecular and systems level, thereby using a wide variety of techniques and approaches.
The Center for Neuropsychiatric Schizophrenia Research (CNSR) conducts multidisciplinary neuropsychiatric research. CNSR hosts a Lundbeck Foundation Center of Excellence for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS).
Cancer research is Europe’s fastest and largest growing field, with 23 % of first round venture investments being commanded by companies focused on this area.
Medicon Valley is home to more than 25 organisations focusing on cancer research, which collectively have over 75 therapeutic compounds in the pipeline.
Rigshospitalet in Copenhagen has a new unit dedicated to Phase I and II cancer research trials, which recruits patients from across Medicon Valley.
At the Sino Danish Breast Cancer Research Center Danish researchers collaborate with leading Chinese geneticists from Beijing Genomics Institute.
Another successful initiative is CREATE Health, which is a strategic centre for clinical cancer research. The centre brings together researchers from diverse fields, such as nanotechnology, proteomics, cancer genetics and tumour cell biology to develop novel cancer treatments and diagnostics.
The MAD for Cancer program is a unique concept in that it brings together several different facets of cancer biology into a multifocal approach. Areas including early diagnosis, patient stratification, targeted therapies attacking every tumour cell type and resilience are studied. The hallmark of this battle is the creative force generated by national and international collaborators from different scientific disciplines.
Inflammation and autoimmune diseases
There are over 20 pioneering companies in Medicon Valley working in the field of arthritis. There are also many world-class research groups exploring arthritis from basic immunology to applied inflammation research. The organisations involved in this research have over 45 compounds in the pipeline.
The university city of Lund has had a lot of commercial success in this area, from developed treatments for allergic asthma to infection control. Here, industry works with academia to create a synergy resulting in one of the most respected centres for inflammation study, prevention, and treatment in the world.
In Denmark there are several research groups counducting research within this area; the Institute for Inflammation Research (University Hospital of Copenhagen), the Centre for Inflammation and Metabolism (CIM) and the Department of Drug Design and Pharmacology (University of Copenhagen).
Stem Cell Research
With the focus on stem cell and developmental biology, the research covers developing stem cells, cell replacement, and gene therapy. Stem cell research has become an integral and important part of the research carried out at Lund Stem Cell Centre at Lund University. This is both as stand-alone research, and as an essential part of other research areas and projects. The aim is to pioneer advancements in new cell therapies, particularly those treating diseases that currently have no treatment options.
The Danish Center for Stem Cell Research (DanStem) at the University of Copenhagen comprises two sections; the Novo Nordisk Foundation Section for Basic Stem Cell Biology and the Section for Strategic Translational Stem Cell Research and Therapy.